Search
Search Results
##search.searchResults.foundPlural##
-
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
2371PDF: 907HTML: 7991Untitled: 212 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1769PDF: 764HTML: 238 -
Fetal hemoglobin modifies the disease manifestation of severe Plasmodium falciparum malaria in adult patients with sickle cell anemia.
3301PDF: 947HTML: 778text and figure: 248 -
LATERAL SINUS THROMBOSIS IN OTOLOGY: A REVIEW
1675PDF: 987HTML: 4178Letter: 192 -
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1883PDF: 610HTML: 253 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2947PDF: 1145HTML: 476Preferred Reviewers: 232 -
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AGGRESSIVE LYMPHOMAS
2678PDF: 900HTML: 2131 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1785PDF: 650HTML: 1556Figure 1: MRI demonstrating Aspergillus synovitis: 203Figure 2:MRI demonstrating Aspergillus synovitis: 210 -
WHAT ARE FUNGAL INFECTIONS?
4314PDF: 2472HTML: 27694de Pauw: 263 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3514PDF: 1234HTML: 504 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1663PDF: 844HTML: 1276Figure 1: 192Figure 2: 206Figure 3: 206 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2133PDF: 1087HTML: 15735COVER LETTER: 210 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2952PDF: 1153HTML: 3073 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4404PDF: 1425HTML: 2187 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
951PDF: 725HTML: 360 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8219PDF: 4435HTML: 7558 -
IMPACT OF QUALITATIVE AND QUANTITATIVE IMMUNOPARESIS ON EARLY INFECTION RISK IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Immunoparesis and early infection risk in myeloma
195PDF: 649HTML: 63 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7953PDF: 751HTML: 253 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3796PDF: 1303HTML: 3926Untitled: 256Untitled: 290 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3000PDF: 1409HTML: 3723Untitled: 214Untitled: 227Untitled: 199 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
5076PDF: 1992HTML: 11448Fig 1: 253Fig 2: 209Fig 3: 334Fig 4: 211Fig 5: 216Fig 6: 207Fig 7: 227Fig 8: 205







